Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00713700 · ClinicalTrials.gov registry record · NA

AMPLATZER Duct Occluder II Clinical Study

A NA study, sponsored by Abbott Medical Devices.

Completed
Registry status
NA
Development phase
192
Enrollment target

NCT00713700 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 192 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00713700, a NA study, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
NA
Development phase
192 participants
Enrollment target

Study Summary

The objective of this study is to investigate the safety and effectiveness of the ADO II in patients with a PDA.

Interventions

  • DEVICE AMPLATZER Duct Occluder II

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2008-08
Est. Completion 2016-10-05
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

What the Registry Record Tells You About NCT00713700

The ClinicalTrials.gov registry entry for NCT00713700 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which AMPLATZER Duct Occluder II is the first listed.

NCT00713700 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00713700 about?

NCT00713700 is a clinical study titled "AMPLATZER Duct Occluder II Clinical Study". The objective of this study is to investigate the safety and effectiveness of the ADO II in patients with a PDA.

What is the current status of trial NCT00713700?

This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2008-08. Estimated completion is 2016-10-05.

What interventions are being tested in trial NCT00713700?

The interventions under investigation include: AMPLATZER Duct Occluder II (DEVICE).

Who is sponsoring clinical trial NCT00713700?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.